Cat: IPD-X41846

Recombinant Human GPATCH4 Protein,His & Myc

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    GPATCH4

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Species

    Human

  • Source

    E. coli

  • Tag

    N- His & C- Myc

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    Q5T3I0

  • Expression Region

    1-190aa

  • Molecular Weight

    28.6 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

GPATCH4, a member of the GPATCH protein family, has gained attention in recent years for its potential roles in various biological processes, including gene regulation and RNA metabolism. The GPATCH domain, characterized by a conserved motif, is thought to interact with RNA molecules and other proteins, suggesting its involvement in post-transcriptional regulation. Research indicates that GPATCH4 may play a crucial role in cellular stress responses and may be implicated in certain diseases, including cancer and neurodegenerative disorders. Previous studies have shown that GPATCH4 can influence the stability and processing of RNA, highlighting its importance in maintaining cellular homeostasis. Understanding the structure and function of GPATCH4, particularly through the development of recombinant protein forms, is essential for elucidating its biological roles and potential therapeutic applications. The production of GPATCH4 recombinant protein allows scientists to investigate its interactions in vitro, contributing to a deeper understanding of its mechanisms and exploitation in drug discovery and development. As the role of GPATCH4 continues to be explored, it holds promise as a target for therapeutic interventions and as a biomarker for specific pathological conditions.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US